A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.
Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.
Patients whose treatment was based on the molecular characteristics of their particular tumor had significantly better outcomes compared with patients who did not.
A study examined the relation between various forms of breast cancer therapies and risk of congestive heart failure.
Patients with classical Hodgkin lymphoma who are resistant to the CD30-directed antibody-drug conjugate brentuximab vedotin have poor outcomes.
High neutrophil to lymphocyte ratio (NLR) is linked to worse prognosis in Caucasian patients with early breast cancer.
Researchers have noted a link between supportive care and reduced risk of adverse outcomes.
An exercise intervention did not improve physical functioning for women living with advanced breast cancer, according to a study.
African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.
Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.
Ob-gyns report external examinations are important for cancer detection and lesion identification.
Improved survival for patients treated by higher-volume radiation oncologists was observed.
Nipple-sparing Mastectomy Offers Better Cosmetic and Psychological Outcomes for Patients With Breast CancerDecember 09, 2015
Nipple-sparing mastectomy and immediate breast reconstruction results in higher reported patient body image, when compared to skin-sparing partial mastectomy (SS-PM), and may lower risk of local recurrence.
Despite growing popularity of patient navigation (PN) in cancer care, few studies have evaluated the impact of PN on patient outcomes.
A new study found that prognosis after treatment for women with breast cancer with a family history of the disease is no worse than it is for other women with breast cancer.
Higher mortality is associated with more narrow margins for high-risk primary melanoma, per research presented at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting in Chicago.
No difference seen in distant disease-free intervals for those with versus those without a positive family history, say researchers.
Current unemployment for head and neck cancer survivors linked to harder physical work, surgical treatment, and risky alcohol consumption.
Improved rates of stage-specific treatment for early- and advanced-stage non-small-cell lung cancer (NSCLC) with comorbid COPD were linked to a pulmonologist's management.
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.
A new study has better established the future risk of developing breast cancer for those with atypical hyperplasia of the breast.
A new test may reveal which patients will respond to treatment for graft-versus-host disease (GVHD), a serious complication that can arise from stem cell SCT.
According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.
The Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgery (ESTS) plan to link their outcomes data on chest procedures, in an effort to improve patient care.
The long-term survival rates following laparoscopic surgery for bladder cancer are not unlike survival rates for open surgery, according to research.
Trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients, according to a large national study.
Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
Biggest increase for time to treatment initiation seen for head and neck cancer patients with advanced disease, chemoradiation, or undergoing treatment at academic center.
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- Up to One-Quarter of Patients With Lung Cancer Ineligible for Immunotherapy
- Imaging Technique Is Predictive of Immunotherapy Response in Non-Small Cell Lung Cancer
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Triple-Drug Therapy Produces Response in Triple-Negative Breast Cancer, Mouse Study Shows
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Study Supports Increased Role for Surgery in Multimodality Therapy for Early Stage SCLC
- Vitamin D and Androgen Receptor-Targeted Therapy Are Effective in Triple-Negative Breast Cancer
- Nonadherence to Noncancer Medication Schedules Predicts Adherence to Adjuvant Hormone Therapy for Breast Cancer
- Premedication With Antiemetic Improves Length of Stay and Readmissions for a Liver Cancer Procedure
- Aspirin Use Found to Prevent Cholangiocarcinoma
- Focal Laser Ablation Feasible and Safe for Treatment of Prostate Cancer
- Lung Cancer Signature Detected Via Breath Test Improves Early Diagnosis
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|